A red-blooded grant

$1.2 million has been awarded to Eric Lazartigues, assistant professor of pharmacology at LSU Health Sciences Center New Orleans School of Medicine by the National Heart, Lung, and Blood Institute with the aim of funding a five-year research proposal to advance our understanding of how the brain regulated blood pressure and affects the development of hypertension. The research could ultimately pave the way for the development of new treatments for cardiovascular disease, a major killer in the developed world. Lazartigues' research group was the first to identify the presence of the protein angiotensin-converting enzyme 2 (ACE2) in the mouse brain. ACE2 degrades the hormone, angiotensin-II, in the brain, and so affects blood pressure.